This year, people on Medicare Part D will not have to pay more than $2,000 in out-of-pocket drug expenditures — and that ...

The opioid epidemic, obesity, federal employee suicide and depression rates, and drug prices are on our readers’ minds.

The supply of GLP-1 drugs like Ozempic has been increasing, but they’re still expensive for most patients. Here are answers ...